Compare HYNE & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HYNE | SRZN |
|---|---|---|
| Founded | 2025 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 115.7M | 210.3M |
| IPO Year | N/A | N/A |
| Metric | HYNE | SRZN |
|---|---|---|
| Price | $14.48 | $26.42 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $36.00 |
| AVG Volume (30 Days) | 24.8K | ★ 66.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.56 | $7.11 |
| 52 Week High | $14.85 | $29.15 |
| Indicator | HYNE | SRZN |
|---|---|---|
| Relative Strength Index (RSI) | 51.12 | 57.67 |
| Support Level | $14.17 | $11.66 |
| Resistance Level | $14.50 | $27.96 |
| Average True Range (ATR) | 0.26 | 2.15 |
| MACD | -0.00 | 0.08 |
| Stochastic Oscillator | 43.48 | 63.04 |
Hoyne Bancorp Inc is a holding company that conducts business mainly through its subsidiaries. It is a savings institution focused on serving customers' banking needs in the market area. The group offers Personal and Business banking services.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).